
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
Amit Bar‐Or, Michael P. Pender, Rajiv Khanna, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 3, pp. 296-310
Open Access | Times Cited: 223
Amit Bar‐Or, Michael P. Pender, Rajiv Khanna, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 3, pp. 296-310
Open Access | Times Cited: 223
Showing 1-25 of 223 citing articles:
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Tobias V. Lanz, R. Camille Brewer, Peggy P. Ho, et al.
Nature (2022) Vol. 603, Iss. 7900, pp. 321-327
Open Access | Times Cited: 584
Tobias V. Lanz, R. Camille Brewer, Peggy P. Ho, et al.
Nature (2022) Vol. 603, Iss. 7900, pp. 321-327
Open Access | Times Cited: 584
Epstein-Barr Virus and Systemic Autoimmune Diseases
Gunnar Houen, Nicole Hartwig Trier
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 268
Gunnar Houen, Nicole Hartwig Trier
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 268
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
Jamie van Langelaar, Liza Rijvers, Joost Smolders, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 227
Jamie van Langelaar, Liza Rijvers, Joost Smolders, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 227
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
Maria Teresa Cencioni, Miriam Mattoscio, Roberta Magliozzi, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 7, pp. 399-414
Closed Access | Times Cited: 176
Maria Teresa Cencioni, Miriam Mattoscio, Roberta Magliozzi, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 7, pp. 399-414
Closed Access | Times Cited: 176
Gene–environment interactions and their impact on human health
Samuel J. Virolainen, Andrew VonHandorf, Kenyatta C. M. F. Viel, et al.
Genes and Immunity (2022) Vol. 24, Iss. 1, pp. 1-11
Open Access | Times Cited: 128
Samuel J. Virolainen, Andrew VonHandorf, Kenyatta C. M. F. Viel, et al.
Genes and Immunity (2022) Vol. 24, Iss. 1, pp. 1-11
Open Access | Times Cited: 128
Age-associated B cells in autoimmune diseases
Isobel C. Mouat, Erin J. Goldberg, Marc S. Horwitz
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 101
Isobel C. Mouat, Erin J. Goldberg, Marc S. Horwitz
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 101
Epstein-Barr virus and multiple sclerosis
William H. Robinson, Lawrence Steinman
Science (2022) Vol. 375, Iss. 6578, pp. 264-265
Open Access | Times Cited: 101
William H. Robinson, Lawrence Steinman
Science (2022) Vol. 375, Iss. 6578, pp. 264-265
Open Access | Times Cited: 101
The effects of exposure to solar radiation on human health
Rachel Ε. Neale, Robyn Lucas, Scott N. Byrne, et al.
Photochemical & Photobiological Sciences (2023) Vol. 22, Iss. 5, pp. 1011-1047
Open Access | Times Cited: 94
Rachel Ε. Neale, Robyn Lucas, Scott N. Byrne, et al.
Photochemical & Photobiological Sciences (2023) Vol. 22, Iss. 5, pp. 1011-1047
Open Access | Times Cited: 94
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 76
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 76
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
de Sèze, Élisabeth Maillart, Antoine Guéguen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 65
de Sèze, Élisabeth Maillart, Antoine Guéguen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 65
An autoantibody signature predictive for multiple sclerosis
Colin R. Zamecnik, Gavin M. Sowa, Ahmed Abdelhak, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1300-1308
Closed Access | Times Cited: 30
Colin R. Zamecnik, Gavin M. Sowa, Ahmed Abdelhak, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1300-1308
Closed Access | Times Cited: 30
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
Chi‐Yan Lee, Koon‐Ho Chan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 15
Chi‐Yan Lee, Koon‐Ho Chan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 15
Molecular signature of Epstein-Barr virus infection in MS brain lesions
Monica Moreno, Noga Or‐Geva, Blake T. Aftab, et al.
Neurology Neuroimmunology & Neuroinflammation (2018) Vol. 5, Iss. 4
Open Access | Times Cited: 101
Monica Moreno, Noga Or‐Geva, Blake T. Aftab, et al.
Neurology Neuroimmunology & Neuroinflammation (2018) Vol. 5, Iss. 4
Open Access | Times Cited: 101
Epstein-Barr Virus and Multiple Sclerosis
Gunnar Houen, Nicole Hartwig Trier, Jette Lautrup Frederiksen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 78
Gunnar Houen, Nicole Hartwig Trier, Jette Lautrup Frederiksen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 78
COVID-19: dealing with a potential risk factor for chronic neurological disorders
Tommaso Schirinzi, Doriana Landi, Claudio Liguori
Journal of Neurology (2020) Vol. 268, Iss. 4, pp. 1171-1178
Open Access | Times Cited: 74
Tommaso Schirinzi, Doriana Landi, Claudio Liguori
Journal of Neurology (2020) Vol. 268, Iss. 4, pp. 1171-1178
Open Access | Times Cited: 74
Thinking outside the box: non-canonical targets in multiple sclerosis
Laura Bierhansl, Hans‐Peter Hartung, Orhan Aktaş, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 578-600
Open Access | Times Cited: 68
Laura Bierhansl, Hans‐Peter Hartung, Orhan Aktaş, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 578-600
Open Access | Times Cited: 68
Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis
Tilman Schneider‐Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 60
Tilman Schneider‐Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 60
EBV-associated diseases: Current therapeutics and emerging technologies
Srishti Chakravorty, Behdad Afzali, Majid Kazemian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Srishti Chakravorty, Behdad Afzali, Majid Kazemian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
Hengameh Shams, Xiaorong Shao, Adam Santaniello, et al.
Brain (2022) Vol. 146, Iss. 2, pp. 645-656
Open Access | Times Cited: 39
Hengameh Shams, Xiaorong Shao, Adam Santaniello, et al.
Brain (2022) Vol. 146, Iss. 2, pp. 645-656
Open Access | Times Cited: 39
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
Nicola Capasso, Eleonora Virgilio, Antonio Covelli, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 25
Nicola Capasso, Eleonora Virgilio, Antonio Covelli, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 25
Autoantibodies are highly prevalent in non–SARS-CoV-2 respiratory infections and critical illness
Allan Feng, Emily Yang, A. R. Moore, et al.
JCI Insight (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 22
Allan Feng, Emily Yang, A. R. Moore, et al.
JCI Insight (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 22
The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis
Sujan Kumar Sarkar, Annie M. L. Willson, Margaret A. Jordan
Journal of Immunology Research (2024) Vol. 2024, pp. 1-31
Open Access | Times Cited: 9
Sujan Kumar Sarkar, Annie M. L. Willson, Margaret A. Jordan
Journal of Immunology Research (2024) Vol. 2024, pp. 1-31
Open Access | Times Cited: 9
The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Caterina Veroni, Francesca Aloisi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Caterina Veroni, Francesca Aloisi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation
Anthony L. Komaroff, Philip E. Pellett, Steven Jacobson
Clinical Microbiology Reviews (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 50
Anthony L. Komaroff, Philip E. Pellett, Steven Jacobson
Clinical Microbiology Reviews (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 50
Targeting B Cells to Modify MS, NMOSD, and MOGAD
Jonas Graf, Jan Mareš, Michael Barnett, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 49
Jonas Graf, Jan Mareš, Michael Barnett, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 49